Category: pharmaceuticals

Ranked: The Most Prescribed Drugs in the U.S.


This post is by Omri Wallach from Visual Capitalist


The Most Prescribed Drugs in the U.S.

Can I share this graphic?
Yes. Visualizations are free to share and post in their original form across the web—even for publishers. Please link back to this page and attribute Visual Capitalist.
When do I need a license?
Licenses are required for some commercial uses, translations, or layout modifications. You can even whitelabel our visualizations. Explore your options.
Interested in this piece?
Click here to license this visualization.

Ranked: The Most Prescribed Drugs in the U.S.

Every day, millions of people in the U.S. take prescribed drugs to help them live their lives.

As our understanding of medicine has evolved, we’ve been able to develop drugs to aid with some of the most common medical conditions—from pain and blood pressure drugs to asthma medication, thyroid treatments, and antidepressants.

This graphic uses prescribed medicines data from the U.S. Agency for Healthcare Research and Quality, released in 2021 for the 2019 calendar year. It also uses supporting drug and health information from MedlinePlus.

What are the Most Prescribed Drugs in America?

Sorting the annual prescribed medicines data by the total number of patients highlights how important and prevalent some drugs are in America.

The most prescribed drug, atorvastatin (sold under brand Lipitor), was prescribed to 24.5 million people in the U.S. in 2019, or 7.5% of the population. It was one of many statin medications listed, which are used to prevent cardiovascular disease and treat abnormal lipid levels.

In fact, a majority of the most (Read more...)

Visualizing the World’s Biggest Pharmaceutical Companies


This post is by Anshool Deshmukh from Visual Capitalist


Bubble map of the largest pharmaceutical companies in the world

Can I share this graphic?
Yes. Visualizations are free to share and post in their original form across the web—even for publishers. Please link back to this page and attribute Visual Capitalist.
When do I need a license?
Licenses are required for some commercial uses, translations, or layout modifications. You can even whitelabel our visualizations. Explore your options.
Interested in this piece?
Click here to license this visualization.

Who are the World’s Biggest Pharmaceutical Companies?

Some of the world’s biggest pharmaceutical companies have played a central role in the COVID-19 pandemic.

However, it’s likely no surprise that the pandemic has also been great for many healthcare businesses. In fact, in 2020 alone, the world’s 50 largest pharmaceutical companies still combined for a whopping $851 billion in revenues.

In this graphic, using data from Companies Market Cap, we list the largest pharmaceutical companies in the world by market capitalization. It’s worth noting this list also includes healthcare companies that work closely with pharmaceuticals, including biotech, pharmaceutical retailers, clinical laboratories, etc.

The Pharmaceutical Leaders

To start, here are the top five biggest pharmaceutical companies in the world at the moment by market capitalization:

1. Johnson & Johnson

The pharmaceutical and consumer goods giant is worth $428.7 billion in market cap. They developed the third vaccine authorized for use in the U.S. and were named among the TIME100 Most Influential Companies List in 2021.

2. Roche

The Swiss pharmaceutical giant is at the forefront of oncology, immunology, (Read more...)

COVID-19 Vaccine Prices: Comparing the U.S. and EU


This post is by Carmen Ang from Visual Capitalist


Vaccines Prices

Can I share this graphic?
Yes. Visualizations are free to share and post in their original form across the web—even for publishers. Please link back to this page and attribute Visual Capitalist.
When do I need a license?
Licenses are required for some commercial uses, translations, or layout modifications. You can even whitelabel our visualizations. Explore your options.
Interested in this piece?
Click here to license this visualization.

The Briefing

  • The U.S. paid 32.1% more per dose for the Pfizer vaccine, compared to the EU
  • Between the two areas, the Sanofi vaccine has one of the smallest prices gaps of only 12.9%

Comparing COVID Vaccine Prices between the U.S. and EU

Over two billion COVID-19 vaccine doses have been administered around the world.

But the price governments have paid for the vaccine varies, depending on the region or country. Here’s a look at five major vaccine manufacturers, and their price per dose in the U.S. compared to the EU.

COVID-19 Vaccine Prices: Cost Per Dose

Generally speaking, the EU has paid significantly less than America for a range of COVID-19 vaccines. Pfizer has the biggest price gap, with the U.S. paying 32.1% more per dose.

ManufacturerU.S. Price (per dose)EU Price (per dose)% Difference U.S. is paying
Pfizer/BioNTech$19.50$14.7632.1%
Moderna$15.00$18.00-20.0%
Sanofi$10.50$9.3012.9%
Johnson & Johnson$10.00$8.5017.6%
AstraZeneca$4.00$3.5014.3%

There are a few factors that might explain the price difference. One is (Read more...)

Here’s What $1,000 Invested in Vaccine Stocks Would Be Worth Now


This post is by Aran Ali from Visual Capitalist


Vaccine stocks performance during the pandemic

The Briefing

  • Three of seven COVID-19 vaccine stocks have outperformed the S&P 500 since the beginning of the global pandemic
  • Novavax is the highest performing vaccine stock, returning 1,549% to shareholders

Vaccine Stocks During a Pandemic

It’s often said that with every crisis comes great opportunity.

While such catastrophes do create upheaval and uncertainty in financial markets, they can also lead to new opportunities for investors, as asset classes react to different environments.

Since the World Health Organization (WHO) declared COVID-19 to be a pandemic on March 11, 2020, the performance of vaccine stocks have been varied—but with some notable winners that notched triple or quadruple digit returns.

Here’s how much a $1,000 investment would be worth as of March 31, 2021, if you had put money into each vaccine stock at the start of the pandemic:

StockValue of Investment% GrowthMarket Cap ($B)
Novavax$16,4911,549.1%$14.3
Moderna$5,019401.9%$59.9
BioNTech$3,247224.7%$31.3
Johnson & Johnson$1,25225.2%$419.8
Pfizer$1,12212.2%$207.2
AstraZeneca$1,12112.1%$93.8
Sanofi$1,0969.6%$105.2

The Business of Vaccines

The returns on vaccine stocks have varied greatly. They are staggering in the case of Novavax and Moderna, but also seem quite underwhelming, when considering the likes of Sanofi, AstraZeneca, and Pfizer.

One factor for the discrepancy in stock price performance is the revenue potential from vaccine sales relative to the rest of the existing business, as vaccine sales will have a much greater impact on the fundamentals of smaller (Read more...)